The news followed an investigation by POLITICO’s E&E News into climate-friendly inhalers and how drug giants are developing them to undermine competition. The pharmaceutical giant AstraZeneca has ...
The Biden administration has reformed Medicare, gone after bogus drug patents and pushed pharmaceutical companies to reduce inhaler costs for patients. “Climate-friendly inhalers” could jeopardize ...
WASHINGTON — Last warning: Asthma inhalers go "green" Dec. 31, forcing patients still using the old-fashioned kind to make a pricey and even confusing switch. The medicine inside these ...
Inhalers are some of the most widely used medical devices and can be lifesaving drugs for the nearly 25 million adults and children who have asthma in the United States. In asthmatics, the disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback